📰 Nasdaq Alks News
Page 11 - Nasdaq Alks News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Alks. Real-time updates on events, politics, business and more.
April 20, 2022
Equities researchers at The Goldman Sachs Group started coverage on shares of Alkermes (NASDAQ:ALKS – Get Rating) in a report released on Wednesday, The Fly reports. The firm set a “buy” rating and a $35.00 price target on the stock. The Goldman Sachs Group’s price target points to a potential upside of 22.89% from the […]
April 19, 2022
Alkermes plc (NASDAQ:ALKS – Get Rating) Director Shane Cooke sold 10,000 shares of the company’s stock in a transaction dated Monday, April 18th. The stock was sold at an average price of $28.88, for a total value of $288,800.00. Following the completion of the transaction, the director now directly owns 90,478 shares of the company’s […]
April 17, 2022
Wall Street brokerages expect Alkermes plc (NASDAQ:ALKS – Get Rating) to announce $0.03 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Alkermes’ earnings. The lowest EPS estimate is ($0.06) and the highest is $0.15. Alkermes posted earnings of $0.11 per share during the same […]
April 14, 2022
Alkermes (NASDAQ:ALKS – Get Rating) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Wednesday. Other equities analysts have also issued research reports about the stock. TheStreet raised shares of Alkermes from a “d+” rating to a “c” rating in a report on Tuesday, March 1st. […]
April 7, 2022
Alkermes plc (NASDAQ:ALKS – Get Rating) Director Shane Cooke sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, April 4th. The shares were sold at an average price of $28.18, for a total transaction of $281,800.00. The sale was disclosed in a filing with the SEC, which can be accessed […]
March 30, 2022
Analysts forecast that Alkermes plc (NASDAQ:ALKS – Get Rating) will announce earnings per share of $0.03 for the current quarter, Zacks Investment Research reports. Five analysts have issued estimates for Alkermes’ earnings. The highest EPS estimate is $0.15 and the lowest is ($0.06). Alkermes posted earnings of $0.11 per share during the same quarter last […]
March 30, 2022
Alkermes plc (NASDAQ:ALKS – Get Rating) shares saw an uptick in trading volume on Wednesday . 97,029 shares changed hands during trading, a decline of 91% from the previous session’s volume of 1,110,160 shares.The stock last traded at $27.05 and had previously closed at $27.99. Several research firms have recently issued reports on ALKS. Mizuho […]
March 11, 2022
Brokerages expect that Alkermes plc (NASDAQ:ALKS – Get Rating) will post earnings per share of $0.03 for the current quarter, according to Zacks. Five analysts have made estimates for Alkermes’ earnings, with estimates ranging from ($0.06) to $0.15. Alkermes posted earnings of $0.11 per share during the same quarter last year, which suggests a negative […]
March 5, 2021
CONTENT: Multimedia with summary Many people with Substance Use Disorder are struggling with isolation during the pandemic. Physicians or healthcare providers can provide guidance during these unprecedented times via The National Institute on Drug Abuse (NIDA): https://bit.ly/3siSeCM
March 3, 2021
CONTENT: Multimedia with summary Though National Cancer Prevention Month has come to an end, Alkermes will not stop working to uncover potential new cancer immunotherapies. Share these tips that may help reduce the risk of cancer and help spread awareness.